State of Wisconsin Investment Board’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-318,654
Closed -$36.9M 2642
2023
Q3
$36.9M Sell
318,654
-46,463
-13% -$4.99M 0.12% 167
2023
Q2
$37.6M Buy
365,117
+10,892
+3% +$1.15M 0.11% 185
2023
Q1
$38.7M Buy
354,225
+180,516
+104% +$20M 0.12% 166
2022
Q4
$19.8M Sell
173,709
-226,217
-57% -$18.8M 0.06% 314
2022
Q3
$24.8M Buy
399,926
+207,435
+108% +$14.5M 0.08% 255
2022
Q2
$15.4M Sell
192,491
-9,879
-5% -$936K 0.04% 444
2022
Q1
$21.3M Sell
202,370
-144,128
-42% -$14M 0.04% 410
2021
Q4
$37.3M Buy
346,498
+54,254
+19% +$5.92M 0.07% 290
2021
Q3
$32M Buy
292,244
+63,776
+28% +$6.62M 0.07% 326
2021
Q2
$21.4M Buy
228,468
+29,555
+15% +$2.72M 0.04% 442
2021
Q1
$18.3M Buy
198,913
+85,836
+76% +$7.24M 0.04% 467
2020
Q4
$8.27M Buy
113,077
+86,930
+332% +$6.46M 0.02% 768
2020
Q3
$2.03M Buy
26,147
+1,990
+8% +$137K 0.01% 1161
2020
Q2
$1.34M Sell
24,157
-1,090
-4% -$46.6K ﹤0.01% 1188
2020
Q1
$748K Sell
25,247
-1,210
-5% -$40.9K ﹤0.01% 1256
2019
Q4
$958K Buy
+26,457
New +$811K ﹤0.01% 1252
2019
Q3
Sell
-261,300
Closed -$6.29M 1614
2019
Q2
$6.29M Buy
261,300
+41,700
+19% +$1.06M 0.02% 765
2019
Q1
$5.8M Buy
219,600
+50,300
+30% +$1.19M 0.02% 788
2018
Q4
$3.31M Buy
169,300
+900
+0.5% +$17.6K 0.01% 876
2018
Q3
$3.3M Hold
168,400
0.01% 953
2018
Q2
$2.79M Buy
168,400
+4,700
+3% +$71.7K 0.01% 951
2018
Q1
$2.33M Hold
163,700
0.01% 950
2017
Q4
$2.39M Buy
163,700
+36,700
+29% +$515K 0.01% 953
2017
Q3
$1.61M Hold
127,000
﹤0.01% 987
2017
Q2
$1.51M Buy
+127,000
New +$1.58M ﹤0.01% 976

Other funds holding HZNP

State of Wisconsin Investment Board's HZNP Position: Q4 2023 in Review

State of Wisconsin Investment Board sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 318,654 shares — an estimated $36.9M sold.

State of Wisconsin Investment Board first reported a position in HZNP in Q2 2017 and held it in 25 quarters. The position peaked at $38.7M in Q1 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • State of Wisconsin Investment Board reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 318,654 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $36.9M.
  • State of Wisconsin Investment Board first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2017 and held it in 25 quarters.
  • State of Wisconsin Investment Board's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $38.7M in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2023, filed 12 Feb 2024.